3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Neoplastic Cells, Circulating
1
Metastatic Neuroendocrine Prostate Cancer
1
Bulbo-Spinal Atrophy, X-Linked
1
Interventions
Blood Specimen Collection
8
cabazitaxel
3
Reverse Transcriptase Polymerase Chain Reaction
2
Flow Cytometry
2
Anesthesia, General
2
Leukapheresis
1
Histamine H2 Antagonists
1
Histamine Antagonists
1
Docetaxel
1
Data Collection
1
Antiemetics
1
Anesthesia, Spinal
1
Analgesia, Epidural
1
Adrenal Cortex Hormones
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplastic Cells, Circulating
×
Antiemetics
×
Genitourinary
×
Clear all
NCT03050866
2021-08-20
CABA-V7
Erasmus Medical Center
Phase 2
Unknown
140 enrolled